Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
MOHRSS Issues the 2017 Edition of NRDL with 339 Additions
The 2017 NRDL includes 2,535 Western and formulated TCMs, 339 or 15.4% more than the 2009 Edition. Among the 2,535, 1,297 are Western medicines and 1,238 are formulated T... (2/23/2017)
   
Figuring Out Reimbursement Policies in China (2/21/2017)
China to Slash Drug Distribution Groups in Price Drive (2/21/2017)
China's State Council Announces Major Policies to Reform the Pharmaceutical Industry (2/21/2017)
China Works to Reduce Massive Backlog of Clinical Trial and Marketing Applications (2/15/2017)
Can Technology Really Solve China's Healthcare Crisis? (2/14/2017)
China's Tech Tycoons' Healthcare Dreams Aren't Coming True (2/13/2017)
Five Elements to Consider When Choosing the Next Emerging Market to Enter (2/13/2017)
China Will Continue To Rise As A Key Base for Global Pharmaceutical Manufacturing (2/8/2017)
PwC: Chinese Hospital M&A Review and Outlook H1/2016 (2/7/2017)
Mobile Medical Healthcare Trends in China (2/6/2017)
Tough and Turbulent Time Ahead in the Coming Year of Trump Rooster - 2016 Annual Review & 2017 Outlook (2/2/2017)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2016 (2/1/2017)
2016 Compliance Enforcement in the Pharmaceutical Industry (1/26/2017)
Are Reforms Focused on Pharma Kickbacks in China, the Last Straw to Push Doctors to Leave? (1/24/2017)
RDPAC Releases New Report on Meeting the Cancer Challenges in China (1/23/2017)
CFDA Solicits Comments for Draft Drug Re...  (2/23/2017)
MOHRSS Issues the 2017 Edition of NRDL w...  (2/23/2017)
WHO: 100 Mln People in China Have Hepati...  (2/22/2017)
Adgero Gets $2M Investment from Fudan-Zh...  (2/22/2017)
Global Pharmerging Market to Grow at a C...  (2/22/2017) (free)
CFDA Issues Notice for Pharmaceutical Te...  (2/22/2017)
CFDA Issues Announcement over Import and...  (2/22/2017)
2017 Spring Promotion for Pharma China P...  (2/22/2017) (free)
Despite Strong Albumin Sales, CSL Compla...  (2/21/2017)
Eisai Acquires China Rights of PD Drugs ...  (2/21/2017)
Neovacs Outlicenses China Rights of IFNα...  (2/21/2017)
Updated: China Issues 13th FYP for Natio...  (2/21/2017)
Three Central Agencies Issue Policy to R...  (2/21/2017)
Upcoming Event: Pharma China Annual Foru...  (2/21/2017) (free)
CFDA Approves Clinical Trial Application...  (2/21/2017) (free)
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
PhRMA Urges USTR to Protect US Innovation Abroad
Trump Wants Big Pharma Cut Outsourcing and Prices, Promi...
Mergermarket: Global Pharma and Biotech M&A Feels th...
Trump Challenges Pharma Outsourcing, Unnerving Drug Make...
GBI: Asia-Pacific Influenza Vaccines Market to Surpass $1.7B by...
Chinese Animal Vaccine Market to Reach CNY 41 Bln by 2020
Data Snapshot - Hospital Consumption COPD Drugs in Shanghai
Deutsche Bank Expects Substantial mAb Market Growth in China
Nicholas Hall: Chinese OTC Drug Sales Growth Slows
Adgero Gets $2M Investment from Fudan-Zhangjiang Biopharma
Despite Strong Albumin Sales, CSL Complains of Barriers in C...
Eisai Acquires China Rights of PD Drugs from Orion Corp.
Neovacs Outlicenses China Rights of IFNα Kinoid Vaccine to ...
Qilu Pharma Launches First Generic of AZ’s Anticancer Iress...
CFDA Solicits Comments for Draft Drug Registration Relat...
CFDA Issues Notice for Pharmaceutical Technology Transfe...
CFDA Issues Announcement over Import and Custom Clearanc...
Updated: China Issues 13th FYP for National Drug Safety
CFDA Releases Three Technical Guidelines for Generic Dru...
China Cracks Down on First Pharma Antimonopoly Case in 2017
China Issues Five Year Plan for Intellectual Property Develo...
USTR Releases 2016 Report on China's WTO Compliance Highligh...
SAIC Fines Southwest No.2 Pharma for API Sales Monopoly
NDRC Fines MedTronic CNY 118.5M for Alleged Price-fixing
India Pressures CFDA to Act and Restore Supply of Rare D...
U.S. FDA Warns Suzhou PharmTech, Putting It on Import Al...
New Report: Prospects of Chinese API Industry Up in the ...
U.S. FDA Warns Chinese Heparin Producer Dongying Tiandon...
India Puts Chinese APIs on Radar over Quality Concerns
CFDA Approves Clinical Trial Applications of Four H7N9 B...
TaiGen Reports Positive Phase II Results for Its HCV Dru...
Sirnaomics Initiates a Clinical Phase IIa Study of Its s...
FirboGen Posts Positive Chinese Phase III Data for AZ-Pa...
WuXi MedImmune Secures CFDA’s Clinical Approval for Pha...
MOHRSS Issues the 2017 Edition of NRDL with 339 Addition...
WHO: 100 Mln People in China Have Hepatitis B or C
Three Central Agencies Issue Policy to Reinforce BMI Bud...
State Council Issues Medium and Long Term Plan for Preve...
MOHRSS Expected to Issue Policy for Uniform BMI Payment ...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Former CFDA Official Handed Ten Year Imprisonment for Corr...
2017 Spring Promotion for Pharma China Publications
Upcoming Event: Pharma China Annual Forum 2017 in Shangh...
Upcoming Event: Pharma China Annual Forum 2017 in Shangh...
Upcoming Event: Cancer Science 2017
Upcoming Event: BioPharma Asia 2017
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links